UPDATE 1-U.S. FDA approves Gilead blood cancer drug Zydelig
July 23, 2014 at 14:21 PM EDT
July 23 (Reuters) - The U.S. Food and Drug Administration said on Wednesday it has approved Gilead Sciences Inc's Zydelig, a drug to treat three types of blood cancer.
